Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Letter to the Editor
JCP
Letter to the Editor
Reversible Dyskinesia During Bupropion Therapy
May 15, 1997
George Gardos
JCP
Letter to the Editor
Benztropine in the Treatment of Venlafaxine-Induced Sweating
April 15, 1997
Aaron Garber
,
Robert J. Gregory
JCP
Letter to the Editor
Bupropion for SSRI-Induced Fatigue
April 15, 1997
Thomas R. Green
JCP
Letter to the Editor
Impact of a Smoking Ban on a Locked Psychiatric Unit
April 15, 1997
Theodore Pearlman
JCP
Letter to the Editor
Novel Use of Tramadol Hydrochloride in the Treatment of Tourette's Syndrome
April 15, 1997
Nathan A. Shapira
,
Brian J. McConville
,
M. Lisa Pagnucco
, et al
JCP
Letter to the Editor
Pharmacologic Properties of Venlafaxine
April 15, 1997
Mary N. Smith
JCP
Letter to the Editor
Reply to Letter to the Editor "Impact of a Smoking Ban on a Locked Psychiatric Unit"
April 15, 1997
Ellen Haller
,
Dale E. NcNiel
,
Renze L. Binder
JCP
Letter to the Editor
Reply to Letter to the Editor "Pharmacologic Properties of Venlafaxine"
April 15, 1997
Robert L. Findling
,
Michael A. Schwartz
,
Daniel J. Flannery
, et al
JCP
Letter to the Editor
Reply to Letter to the Editor "Stereotypic Movement Disorder"
April 15, 1997
F. Xavier Castellanos
,
Judith L. Rapoport
JCP
Letter to the Editor
Safety of Amobarbital
April 15, 1997
W. Vaughn McCall
JCP
Letter to the Editor
Stereotypic Movement Disorder
April 15, 1997
Dan J. Stein
,
Colin Bouwer
,
Dana J. Niehaus
JCP
Letter to the Editor
Transient, Paroxysmal, Shock-Like Paresthesias Associated With Paroxetine Initiation
April 15, 1997
CPT Timothy R. Berigan
,
MAJ Anne W. Cannard
,
MAJ Kevin R. Cannard
JCP
Letter to the Editor
Acute Angle-Closure Glaucoma and Paroxetine
March 15, 1997
Catherine F. Lewis
,
John R. DeQuardo
,
Charles DuBose
, et al
JCP
Letter to the Editor
The Differential Diagnosis of Multiple Sclerosis and Bipolar Disorder
March 15, 1997
Carl R. Young
,
Erica L. Weiss
,
Malcolm B. Bowers, Jr.
, et al
JCP
Letter to the Editor
Dose-Related Thrombocytopenia and Macrocytic Anemia Associated With Valproate Use in Bipolar Disorder
March 15, 1997
Robert G. Fawcett
JCP
Letter to the Editor
Fluoxetine Efficacy in Social Phobia
March 15, 1997
Leslie v. H. Taylor
JCP
Letter to the Editor
Body Dysmorphic Disorder by Proxy
February 15, 1997
Stephen C. Josephson
,
Eric Hollander
JCP
Letter to the Editor
Dyskinesia With Fluoxetine: Tardive or Late-Onset Persistent, Acute Norfluoxetine Dyskinesia?
February 15, 1997
Edward C. Lauterbach
,
Samuel D. Shillcutt
JCP
Letter to the Editor
Mania Associated With Serotonin Selective Reuptake Inhibitors
February 15, 1997
Christine Vesely
,
Peter Fischer
,
Ralph Goessler
, et al
JCP
Letter to the Editor
Sertraline-Induced Anorgasmia Treated With Intermittent Nefazodone
February 15, 1997
Ronald D. Reynolds
JCP
Letter to the Editor
Sertraline Treatment of Hallucinogen Persisting Perception Disorder
February 15, 1997
Carl R. Young
JCP
Letter to the Editor
SSRI Optimal Dose Remains at Issue
February 15, 1997
Arthur Rifkin
JCP
Letter to the Editor
Akathisia as Violence
January 15, 1997
Igor I. Galynker
,
Deborah Nazarian
JCP
Letter to the Editor
Cessation of Self-Mutilation in a Patient With Borderline Personality Disorder Treated With Naltrexone
January 15, 1997
Michael D. McGee
«
1
…
83
84
85
86
87
»
